Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Diego, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Crinetics Pharmaceuticals, Inc. has filed 671 SEC EDGAR filings since 16 Nov 2015

SEC filing history

Showing 226-250 of 671 matching filings.

Per page
25
Current page
10
144 File 001-38583

144 filing

Filing date
21 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
20 Mar 2024
Reporting date
18 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
20 Mar 2024
Reporting date
18 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
20 Mar 2024
Reporting date
18 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
20 Mar 2024
Reporting date
18 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
20 Mar 2024
Reporting date
18 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
20 Mar 2024
Reporting date
18 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38583

144 filing

Filing date
20 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38583

144 filing

Filing date
20 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38583

144 filing

Filing date
19 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3ASR File 333-278060

S-3ASR

Filing date
19 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-507240

D filing

Filing date
11 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-90577

SC 13G filing

Filing date
11 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
06 Mar 2024
Reporting date
04 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
06 Mar 2024
Reporting date
04 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
06 Mar 2024
Reporting date
04 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
06 Mar 2024
Reporting date
04 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
06 Mar 2024
Reporting date
04 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
06 Mar 2024
Reporting date
04 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-90577

SC 13D/A

Filing date
01 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-277484

S-8 POS

Filing date
01 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-277484

S-8

Filing date
29 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .